Evidence map›Paper›PMID 38470254›Full record

ArticlemSphere2024

CSPG4-dependent cytotoxicity for

D Annie Doyle, Paul L DeAngelis, Jimmy D Ballard

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Mechanisms ofFrontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

D Annie DoyleDepartment of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID 0000-0003-4388-3897
Paul L DeAngelisDepartment of Biochemistry and Physiology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Jimmy D BallardDepartment of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID 0000-0001-8824-9609
University of Oklahoma Health Sciences Center · US

Funding

Differential Effects of TcdB1 and TcdB2 in C. difficile diseaseR01AI119048 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BALLARD, JIMMY D. · 2015 to 2024
$3.8M
NIAID NIH HHS R01 AI119048
6 · The paper itself

Abstract

TcdB is an intracellular bacterial toxin indispensable to IMPORTANCE:

Indexed as

Bacterial ProteinsBacterial ToxinsCalciumChondroitin Sulfate ProteoglycansChondroitin SulfatesClostridioides difficileMembrane ProteinsCell LineChondroitin Sulfate Proteoglycan 4HumansProtein BindingBacterial ProteinsBacterial ToxinsCalciumChondroitin Sulfate Proteoglycan 4Chondroitin Sulfate ProteoglycansChondroitin SulfatesCSPG4 protein, humanMembrane ProteinstoxB protein, Clostridium difficilecalciumchondroitin sulfateClostridioides difficileTcdB

Identifiers

PMID38470254
PMCPMC11036797
OpenAlexW4392702687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.